The identification of transcriptional targets of ascl1 in oligodendrocyte development

GLIA

Volumn 60, Issue 10, 2012, Pages 1495-1505

  Ueno, Takaaki ^a,b   Ito, Junichi ^a,b   Hoshikawa, Shinya ^a   Ohori, Yasuo ^a   Fujiwara, Sayaka ^b   Yamamoto, Shinichi ^a   Ohtsuka, Toshiyuki ^c   Kageyama, Ryoichiro ^c   Akai, Masami ^a   Nakamura, Kozo ^b   Ogata, Toru ^a  

^a NATIONAL REHABILITATION CENTER FOR PERSONS WITH DISABILITIES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Ascl1; BHLH transcription factor; Oligodendrocyte development

Indexed keywords

TRANSCRIPTION FACTOR HES 5; TRANSCRIPTION FACTOR MASH1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; E BOX ELEMENT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; MICROARRAY ANALYSIS; MOUSE; NEGATIVE FEEDBACK; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROCYTE DEVELOPMENT; OLIGODENDROGLIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPINAL CORD; TELENCEPHALON;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; EMBRYO, MAMMALIAN; FEMALE; GALACTOSYLCERAMIDASE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PREGNANCY; RATS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; STEM CELLS; TRANSFECTION;

EID: 84865308707     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22369     Document Type: Article

References (53)

1. Akazawa C, Sasai Y, Nakanishi S, Kageyama R. 1992. Molecular characterization of a rat negative regulator with a basic helix-loop-helix structure predominantly expressed in the developing nervous system. J Biol Chem 267: 21879-21885.
2. Battiste J, Helms AW, Kim EJ, Savage TK, Lagace DC, Mandyam CD, Eisch AJ, Miyoshi G, Johnson JE. 2007. Ascl1 defines sequentially generated lineage-restricted neuronal and oligodendrocyte precursor cells in the spinal cord. Development 134: 285-293.
3. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81: 871-927.
4. Blakemore WF, Keirstead HS. 1999. The origin of remyelinating cells in the central nervous system. J Neuroimmunol 98: 69-76.
5. Casarosa S, Fode C, Guillemot F. 1999. Mash1 regulates neurogenesis in the ventral telencephalon. Development 126: 525-534.
6. Cau E, Casarosa S, Guillemot F. 2002. Mash1 and Ngn1 control distinct steps of determination and differentiation in the olfactory sensory neuron lineage. Development 129: 1871-1880.
7. Cau E, Gradwohl G, Casarosa S, Kageyama R, Guillemot F. 2000. Hes genes regulate sequential stages of neurogenesis in the olfactory epithelium. Development 127: 2323-2332.
8. Espinosa de los Monteros A, Zhang M, De Vellis J. 1993. O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci USA 90: 50-54.
9. Franklin RJ, Hinks GL. 1999. Understanding CNS remyelination: clues from developmental and regeneration biology. J Neurosci Res 58: 207-213.
10. Gaiano N, Fishell G. 2002. The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci 25: 471-490.
11. Gokhan S, Marin-Husstege M, Yung SY, Fontanez D, Casaccia-Bonnefil P, Mehler MF. 2005. Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. J Neurosci 25: 8311-8321.
12. Guillemot F, Lo LC, Johnson JE, Auerbach A, Anderson DJ, Joyner AL. 1993. Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75: 463-476.
13. Honjo T. 1996. The shortest path from the surface to the nucleus: RBP-J kappa/Su(H) transcription factor. Genes Cells 1: 1-9.
14. Hoshikawa S, Ogata T, Fujiwara S, Nakamura K, Tanaka S. 2008. A novel function of RING finger protein 10 in transcriptional regulation of the myelin-associated glycoprotein gene and myelin formation in Schwann cells. PLoS One 3: e3464.
15. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. 1995. Signalling downstream of activated mammalian Notch. Nature 377: 355-358.
16. Johnson JE, Birren SJ, Saito T, Anderson DJ. 1992. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer. Proc Natl Acad Sci USA 89: 3596-3600.
17. Kagawa T, Wada T, Ikenaka K. 2001. Regulation of oligodendrocyte development. Microsc Res Tech 52: 740-745.
18. Kageyama R, Ohtsuka T. 1999. The Notch-Hes pathway in mammalian neural development. Cell Res 9: 179-188.
19. Keirstead HS, Blakemore WF. 1999. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol 468: 183-197.
20. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD. 2006. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 9: 173-179.
21. Kim EJ, Leung CT, Reed RR, Johnson JE. 2007. In vivo analysis of Ascl1 defined progenitors reveals distinct developmental dynamics during adult neurogenesis and gliogenesis. J Neurosci 27: 12764-12774.
22. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai H. 2003. Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genomics. Exp Hematol 31: 1007-1014.
23. Kondo T, Raff M. 2000a. Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development 127: 2989-2998.
24. Kondo T, Raff M. 2000b. The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J 19: 1998-2007.
25. Kotter MR, Li WW, Zhao C, Franklin RJ. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328-332.
26. Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D, Davis RJ. 2002. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22: 4929-4942.
27. Liu A, Li J, Marin-Husstege M, Kageyama R, Fan Y, Gelinas C, Casaccia-Bonnefil P. 2006. A molecular insight of Hes5-dependent inhibition of myelin gene expression: old partners and new players. EMBO J 25: 4833-4842.
28. Louis JC, Magal E, Muir D, Manthorpe M, Varon S. 1992. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res 31: 193-204.
29. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. 2002. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109: 75-86.
30. Mansour SJ, Resing KA, Candi JM, Hermann AS, Gloor JW, Herskind KR, Wartmann M, Davis RJ, Ahn NG. 1994. Mitogen-activated protein (MAP) kinase phosphorylation of MAP kinase kinase: determination of phosphorylation sites by mass spectrometry and site-directed mutagenesis. J Biochem 116: 304-314.
31. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
32. McMorris FA, McKinnon RD. 1996. Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease. Brain Pathol 6: 313-329.
33. McTigue DM, Horner PJ, Stokes BT, Gage FH. 1998. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18: 5354-5365.
34. Meredith A, Johnson JE. 2000. Negative autoregulation of Mash1 expression in CNS development. Dev Biol 222: 336-346.
35. Ogata T, Ueno T, Hoshikawa S, Ito J, Okazaki R, Hayakawa K, Morioka K, Yamamoto S, Nakamura K, Tanaka S and others. 2011. Hes1 functions downstream of growth factors to maintain oligodendrocyte lineage cells in the early progenitor stage. Neuroscience 176: 132-141.
36. Ohtsuka T, Imayoshi I, Shimojo H, Nishi E, Kageyama R, McConnell SK. 2006. Visualization of embryonic neural stem cells using Hes promoters in transgenic mice. Mol Cell Neurosci 31: 109-122.
37. Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. 1999. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J 18: 2196-2207.
38. Parras CM, Galli R, Britz O, Soares S, Galichet C, Battiste J, Johnson JE, Nakafuku M, Vescovi A, Guillemot F. 2004. Mash1 specifies neurons and oligodendrocytes in the postnatal brain. EMBO J 23: 4495-4505.
39. Parras CM, Hunt C, Sugimori M, Nakafuku M, Rowitch D, Guillemot F. 2007. The proneural gene Mash1 specifies an early population of telencephalic oligodendrocytes. J Neurosci 27: 4233-4242.
40. Pattyn A, Guillemot F, Brunet JF. 2006. Delays in neuronal differentiation in Mash1/Ascl1 mutants. Dev Biol 295: 67-75.
41. Raff MC. 1989. Glial cell diversification in the rat optic nerve. Science 243: 1450-1455.
42. Richardson WD, Kessaris N, Pringle N. 2006. Oligodendrocyte wars. Nat Rev Neurosci 7: 11-18.
43. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S. 1992. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev 6(12B): 2620-2634.
44. Schwarz JJ, Chakraborty T, Martin J, Zhou JM, Olson EN. 1992. The basic region of myogenin cooperates with two transcription activation domains to induce muscle-specific transcription. Mol Cell Biol 12: 266-275.
45. Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H. 2002. CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes. J Neurosci Res 69: 305-317.
46. Sugimori M, Nagao M, Bertrand N, Parras CM, Guillemot F, Nakafuku M. 2007. Combinatorial actions of patterning and HLH transcription factors in the spatiotemporal control of neurogenesis and gliogenesis in the developing spinal cord. Development 134: 1617-1629.
47. Sugimori M, Nagao M, Parras CM, Nakatani H, Lebel M, Guillemot F, Nakafuku M. 2008. Ascl1 is required for oligodendrocyte development in the spinal cord. Development 135: 1271-1281.
48. Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y. 2002. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol 12: 1157-1163.
49. Takebayashi K, Akazawa C, Nakanishi S, Kageyama R. 1995. Structure and promoter analysis of the gene encoding the mouse helix-loop-helix factor HES-5. Identification of the neural precursor cell-specific promoter element. J Biol Chem 270: 1342-1349.
50. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA. 1998. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21: 63-75.
51. Wu Y, Liu Y, Levine EM, Rao MS. 2003. Hes1 but not Hes5 regulates an astrocyte versus oligodendrocyte fate choice in glial restricted precursors. Dev Dyn 226: 675-689.
52. Yang Z, Watanabe M, Nishiyama A. 2005. Optimization of oligodendrocyte progenitor cell culture method for enhanced survival. J Neurosci Methods 149: 50-56.
53. Zhou Q, Anderson DJ. 2002. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109: 61-73.